The popularity of Viagra initially drove a period of growth for pharma, however recent changes present a complicated picture for shareholders. Generic competitors are eating into earnings, and persistent patent https://aadamtjsm748347.slypage.com/41738565/sildenafil-and-the-pharmaceutical-industry-a-risky-bet